AUS
NZ
UK
CA
USA
IND
Highlights
- Telix to list ADSs on Nasdaq under ticker "TLX".
- Part of Telix's plan to broaden its global investor base and enhance its U.S. operations.
- Telix will continue to be primarily listed on the ASX.
Shares of Telix Pharmaceuticals Limited (ASX:TLX) jumps over 3% on Friday as the compny has taken a significant step toward expanding its global presence by publicly filing a Form 20-F registration statement with the U.S. Securities and Exchange Commission (SEC). This registration is in connection with the company’s plan to list American Depository Shares (ADS) on the Nasdaq Stock Market under the ticker symbol "TLX."
Key Aspects of the Nasdaq Listing
- Level II ADR Program: The proposed listing will be established as a Level II American Depositary Receipt (ADR) program, which simplifies access to Telix shares for U.S. investors and improves liquidity.
- No New Shares Issued: Telix clarified that it does not plan to raise capital or issue new shares as part of this listing. The purpose is to broaden access to its stock for U.S. and global investors rather than seeking additional funding.
- Strategic Goal: By listing on Nasdaq, Telix aims to enhance its visibility and attractiveness within the biopharmaceutical sector, the largest market globally for healthcare stocks. This aligns with Telix's goal to diversify its investor base and increase its appeal to U.S. employees by offering equity-related incentives.
Expanding Presence in North America
Telix has been steadily growing its commercial and operational footprint in North America, with a significant portion of its workforce now based in the U.S. The Nasdaq listing is seen as a natural progression of the company's strategy to expand its influence in the U.S. market.
Primary ASX Listing Maintained
Despite the proposed Nasdaq listing, Telix will maintain its primary listing on the Australian Securities Exchange (ASX). Each American Depository Share on Nasdaq will represent one fully paid ordinary share of Telix, allowing investors to trade the same equity on two major global exchanges.
Timeline and Next Steps
The Nasdaq listing will take place after regulatory review by the SEC and Nasdaq. However, Telix cautions that the timing and occurrence of the listing depend on the successful completion of these regulatory processes, and there is no guaranteed timeline for the listing.
